Insights into the action of the pharmaceutical metformin: Targeted inhibition of the gut microbial enzyme agmatinase
Lambros J. Tassoulas,
No information about this author
Lawrence P. Wackett
No information about this author
iScience,
Journal Year:
2024,
Volume and Issue:
27(2), P. 108900 - 108900
Published: Jan. 12, 2024
Metformin
is
the
first-line
treatment
for
type
2
diabetes,
yet
its
mechanism
of
action
not
fully
understood.
Recent
studies
suggest
metformin's
interactions
with
gut
microbiota
are
responsible
exerting
therapeutic
effects.
In
this
study,
we
report
that
metformin
targets
microbial
enzyme
agmatinase,
as
a
competitive
inhibitor,
which
may
impair
agmatine
catabolism.
The
inhibition
constant
(K
Language: Английский
Adaptation towards catabolic biodegradation of trace organic contaminants in activated sludge
Carolin Seller-Brison,
No information about this author
Antoine Brison,
No information about this author
Yaochun Yu
No information about this author
et al.
Water Research,
Journal Year:
2024,
Volume and Issue:
266, P. 122431 - 122431
Published: Sept. 11, 2024
Trace
organic
contaminants
(TrOCs)
are
omnipresent
in
wastewater
treatment
plants
(WWTPs),
yet,
their
removal
during
is
oftentimes
incomplete
and
underlying
biotransformation
mechanisms
not
fully
understood.
In
this
study,
we
elucidate
how
different
factors,
including
pre-exposure
levels
duration,
influence
microbial
adaptation
towards
catabolic
TrOC
biodegradation
its
potential
role
biological
treatment.
Four
sequencing
batch
reactors
(SBRs)
were
operated
parallel
three
succeeding
phases,
adding
removing
a
selection
of
26
TrOCs
at
concentration
levels.
After
each
phase
SBR
operation,
series
experiments
was
conducted
to
monitor
kinetics
those
same
across
various
spike
concentrations.
For
half
our
test
TrOCs,
detected
increased
sludge
pre-exposed
concentrations
≥5
µg
L
Language: Английский
Discovery of a Ni2+-dependent heterohexameric metformin hydrolase
Tao Li,
No information about this author
Zhi-Jing Xu,
No information about this author
Shuting Zhang
No information about this author
et al.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: July 20, 2024
The
biguanide
drug
metformin
is
a
first-line
blood
glucose-lowering
medication
for
type
2
diabetes,
leading
to
its
presence
in
the
global
environment.
However,
little
known
about
fate
of
by
microbial
catabolism.
Here,
we
characterize
Ni
Language: Английский
Metformin hydrolase is a recently evolved nickel-dependent heteromeric ureohydrolase
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Sept. 13, 2024
Abstract
The
anti-diabetic
drug
metformin
is
one
of
the
most
widely
prescribed
medicines
in
world.
Together
with
its
degradation
product
guanylurea,
it
a
major
pharmaceutical
pollutant
wastewater
treatment
plants
and
surface
waters.
An
operon
comprising
two
genes
ureohydrolase
family
Pseudomonas
Aminobacter
species
has
recently
been
implicated
degradation.
However,
corresponding
proteins
have
not
characterized.
Here
we
show
that
these
encode
Ni
2+
-dependent
enzyme
efficiently
specifically
hydrolyzes
to
guanylurea
dimethylamine.
active
heteromeric
complex
α-
β-
subunits
which
only
α-subunits
contain
conserved
His
Asp
residues
for
coordination
ions
site.
A
crystal
structure
hydrolase
reveals
an
α
2
β
4
stoichiometry
hexameric
complex,
unprecedented
family.
By
studying
closely
related
but
more
distributed
enzyme,
find
putative
predecessor
dimethylguanidine
instead
metformin.
Our
findings
establish
molecular
basis
hydrolysis
as
primary
pathway
biodegradation
provide
insight
into
recent
evolution
response
anthropogenic
compound.
Language: Английский
Biochemical and genomic evidence for converging metabolic routes of metformin and biguanide breakdown in environmental Pseudomonads
Katie B. Wissbroecker,
No information about this author
Anthony J. Zmuda,
No information about this author
Harsheeth Karumanchi
No information about this author
et al.
Journal of Biological Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown, P. 107935 - 107935
Published: Oct. 1, 2024
Language: Английский
One his, two his…the emerging roles of histidine in cellular nickel trafficking
Journal of Inorganic Biochemistry,
Journal Year:
2024,
Volume and Issue:
259, P. 112668 - 112668
Published: July 17, 2024
Language: Английский
A prescription for engineering PFAS biodegradation
Lawrence P. Wackett,
No information about this author
Serina L. Robinson
No information about this author
Biochemical Journal,
Journal Year:
2024,
Volume and Issue:
481(23), P. 1757 - 1770
Published: Nov. 25, 2024
Per-
and
polyfluorinated
chemicals
(PFAS)
are
of
rising
concern
due
to
environmental
persistence
emerging
evidence
health
risks
humans.
Environmental
is
largely
attributed
a
failure
microbes
degrade
PFAS.
PFAS
recalcitrance
has
been
proposed
result
from
chemistry,
specifically
C-F
bond
strength,
or
biology,
negative
selection
fluoride
toxicity.
Given
natural
evolution
many
hurdles,
this
review
advocates
for
strategy
laboratory
engineering
evolution.
Enzymes
identified
participate
in
defluorination
reactions
have
discovered
all
Enzyme
Commission
classes,
providing
palette
metabolic
engineering.
In
vivo
biodegradation
will
require
multiple
types
powerful
mitigation
mechanisms
act
concert.
The
necessary
steps
to:
(1)
engineer
bacteria
that
survive
very
high,
unnatural
levels
fluoride,
(2)
design,
evolve,
screen
enzymes
cleave
C–F
bonds
broader
array
substrates,
(3)
create
overall
physiological
conditions
make
positive
selective
pressure
with
substrates.
Language: Английский